NorstellaLinQ: Refining Rare Disease Targeting with Real-World Data

Understand how intermediate-risk cancer patients are diagnosed & treated.

Learn diagnosis and treatment information for rare disease patients with an uncommon ICD-10 code and biomarker tests.

Identify patients’ treatment journeys and target HCPs treating the condition.

norstellalinq-refining-rare-disease-targeting-with-real-world-data

A mid-sized pharma company needed to identify patients for a rare disease and complex indication. In this use case, learn how MMIT, using NorstellaLinQ, identified a narrower patient population and improved the client’s physician targeting and marketing efforts.

Real-World Data Solutions

Payer Data Intelligence Solutions

Payer and Provider Market Research

Payer and Specialty Pharmacy Solutions

Promotional Solutions

Market Access

Patient Journey

Brand Performance and Strategy

Contracting and Reimbursement

NorstellaLinQ: Refining Rare Disease Targeting with Real-World Data

Download the Use Case